Results 211 to 220 of about 1,013,409 (339)

Coronary Artery Vasculopathy in a Cohort of Heart Transplant Recipients: A Single Center Experience

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary allograft vasculopathy (CAV) is a significant cause of late mortality in heart transplant recipients. This study assesses the development of CAV, associated rejection rates, and the potential impact of percutaneous coronary intervention (PCI) on survival in a cohort of heart transplant patients.
Hussein Krayem   +4 more
wiley   +1 more source

Low regulatory T-cells frequency is associated with graft rejection after small bowel transplantation: Clinical and experimental evidence. [PDF]

open access: yesPLoS One
Papa-Gobbi R   +14 more
europepmc   +1 more source

EVIDENCE FOR THE INVOLVEMENT OF HOST-DERIVED OKT8-POSITIVE T CELLS IN THE REJECTION OF T-DEPLETED, HLA-IDENTICAL BONE MARROW GRAFTS

open access: bronze, 1987
Donald Bunjes   +8 more
openalex   +1 more source

Controlling polymer addition flowrate to improve the flocculation of kaolinite suspensions as models for oil sands mature fine tailings

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
Abstract Oil sands exploration generates large volumes of mature fine tailings—mixtures of clays, water, and residual bitumen—that remain stable even after settling in tailings ponds for many years. Commonly used flocculants, such as neutral and anionic polyacrylamides, destabilize the colloidal interactions between the clay particles, but ...
Kilian Slöetjes, João B. P. Soares
wiley   +1 more source

Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic‐Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Alemtuzumab is a T cell‐depleting monoclonal antibody that is used for the prevention of kidney transplant rejection. The duration of lymphodepletion after the current standard induction therapy dose is likely longer than necessary, resulting in prolonged T cell lymphopenia with the associated risk of infections. Here, the interplay between alemtuzumab
Lukas K. van Vugt   +8 more
wiley   +1 more source

Antibodies Against Anti-Oxidant Enzymes in Autoimmune Glomerulonephritis and in Antibody-Mediated Graft Rejection. [PDF]

open access: yesAntioxidants (Basel)
Bruschi M   +7 more
europepmc   +1 more source

Cutting Edge: Linked Suppression of Skin Graft Rejection Can Operate Through Indirect Recognition [PDF]

open access: bronze, 1998
Matt P. Wise   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy